Craig W Hendrix
Overview
Explore the profile of Craig W Hendrix including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
202
Citations
7023
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Achilles S, Kelly C, Hoesley C, Blithe D, Brown J, Richardson B, et al.
PLoS One
. 2024 Jun;
19(6):e0304552.
PMID: 38838028
Background: Vaginal rings formulated to deliver two drugs simultaneously have potential as user-controlled, long-acting methods for dual prevention of HIV and pregnancy. Methods: Two phase 1 randomized trials (MTN-030/IPM 041...
12.
Massih S, Atta M, Thio C, Tornheim J, Fuchs E, Bakshi R, et al.
AIDS Res Ther
. 2024 May;
21(1):34.
PMID: 38773606
Introduction: Peritoneal dialysis (PD) is an effective renal replacement modality in people with HIV (PWH) with end-stage kidney disease (ESKD), particularly those with residual kidney function. Data on pharmacokinetics (PK)...
13.
Matthews L, Jaggernath M, Kriel Y, Smith P, Haberer J, Baeten J, et al.
AIDS
. 2024 May;
38(9):1342-1354.
PMID: 38752557
Objective: We developed the Healthy Families-PrEP intervention to support HIV-prevention during periconception and pregnancy. We evaluated preexposure prophylaxis (PrEP) use with three objective measures. Design: This single-arm intervention study enrolled...
14.
Riddler S, Kelly C, Hoesley C, Ho K, Piper J, Edick S, et al.
J Infect Dis
. 2024 Apr;
230(3):696-705.
PMID: 38655842
Background: On-demand topical products could be an important tool for human immunodeficiency virus (HIV) prevention. We evaluated the safety, pharmacokinetics, and ex vivo pharmacodynamics of a tenofovir alafenamide/elvitegravir (TAF/EVG, 20 ...
15.
Weld E, Ogasawara K, Fuchs E, Louissaint N, Caffo B, Hendrix C
J Acquir Immune Defic Syndr
. 2024 Feb;
PMID: 38346420
Background: Anal sex remains the greatest HIV transmission risk for men who have sex with men and carries substantial population attributable risk among women. Despite a growing array of HIV...
16.
Stalter R, Dong T, Hendrix C, Palanee-Phillips T, van der Straten A, Hillier S, et al.
J Infect Dis
. 2023 Dec;
229(4):1158-1165.
PMID: 38099506
Background: Confounding introduced by individuals' sexual risk behavior is potentially a significant source of bias in HIV-1 prevention intervention studies. To more completely account for sexual behaviors when assessing the...
17.
Weld E, McGowan I, Anton P, Fuchs E, Ho K, Carballo-Dieguez A, et al.
J Infect Dis
. 2023 Nov;
229(4):1131-1140.
PMID: 38019657
Background: Despite highly effective HIV preexposure prophylaxis (PrEP) options, no options provide on-demand, nonsystemic, behaviorally congruent PrEP that many desire. A tenofovir-medicated rectal douche before receptive anal intercourse may provide...
18.
Zhang L, Iannuzzi S, Chaturvedula A, Irungu E, Haberer J, Hendrix C, et al.
Nat Med
. 2023 Nov;
29(11):2753-2762.
PMID: 37957377
Most human immunodeficiency virus (HIV) infections occur in cisgender women in resource-limited settings. In women, self-protection with emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis (FTC/TDF-PrEP) constitutes a major pillar of HIV prevention....
19.
Landovitz R, Hanscom B, Clement M, Tran H, Kallas E, Magnus M, et al.
Lancet HIV
. 2023 Nov;
10(12):e767-e778.
PMID: 37952550
Background: Injectable cabotegravir was superior to daily oral tenofovir disoproxil fumarate plus emtricitabine for HIV prevention in two clinical trials. Both trials had the primary aim of establishing the HIV...
20.
Scott R, Yu Y, Marzinke M, Coleman J, Hendrix C, Bies R
Front Reprod Health
. 2023 Oct;
5:1224580.
PMID: 37830105
Objective: To evaluate upward-adjustment of tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) pre-exposure prophylaxis (PrEP) dosing during pregnancy in order to maintain target plasma concentrations associated with HIV protection. Design: Population pharmacokinetic...